PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|September 2, 2021
- Pharmaceutical Technology, September 2021 Issue
- Volume 45
- Issue 9
Filling Equipment for Small Batches
The Versynta FFP provides a flexible filling solution for liquid pharmaceuticals.
Syntegon’s Versynta Flexible Filling Platform (FFP) is a modular small batch solution designed to be a single-source solution for the entire filling process. The integrated isolator allows filling of aseptic and highly potent liquid active ingredients.
Versynta FFP can be converted to different container types such as vials, syringes, and cartridges, as well as different filling systems including single-use solutions. Instead of entire modules, only format parts need to be replaced.
The Pharma Handling Unit, a four-axis robot developed by Syntegon, allows for safe and gentle transport. It transfers containers from one station to the next without glass-to-glass contact.
Articles in this issue
about 5 years ago
On Time Delivery: Challenges of Controlled-Release Formulationsabout 5 years ago
Getting a Nose for Vaccinesabout 5 years ago
How Pure is Pure? Understanding Reagent Purity Gradesabout 5 years ago
The Impact of Insufficient Oversightabout 5 years ago
Moving Out of the Lab to Optimize Microbial Controlabout 5 years ago
Stepping Up the Search for Unknown Impuritiesabout 5 years ago
Looking Ahead to Factors Shaping Market Activityabout 5 years ago
Improve Automation, but Beware of the PitfallsRelated to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.